Keyphrases
Non-muscle Invasive Bladder Cancer (NMIBC)
100%
Adherence to Guidelines
100%
Urologic Oncology
100%
Guideline-based Management
100%
Low-risk Patients
50%
American Urological Association
50%
Intermediate Risk
50%
High Risk
25%
Imaging Biomarkers
25%
Statistical Analysis
25%
Fellowship Training
25%
Clinical High Risk
25%
Low Risk
25%
Targeted Intervention
25%
Cystoscopic
25%
Clinical Experience
25%
Value-based Care
25%
Online Survey
25%
Evidence-based Guidelines
25%
Risk Category
25%
Initial Diagnosis
25%
Cancer Guidelines
25%
Pearson's chi-square Test
25%
Cystoscopy
25%
Low-risk Disease
25%
Guideline Adherence
25%
Surveillance Interval
25%
Qualtrics
25%
Diagnosis Biomarker
25%
SE Germany
25%
Medicine and Dentistry
Non Muscle Invasive Bladder Cancer
100%
Urologic Oncology
100%
Cytotechnology
25%
Biological Marker
25%
Cystoscopy
25%
Protocol Compliance
25%
Chi Square Test
25%
Diseases
25%